ETD001 single dose
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Enterprise Therapeutics Ltd
Overview
ETD001 single dose is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
ETD001 single dose clinical trials
Explore related
Medical disclaimer. This page summarizes research about ETD001 single dose for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.